If you'd like to view this email in a Web browser, please click here
  
September | October 2012 Newsletter
In This Issue
                
Cayston Restricitions Lifted

FC Website Facelift
          
Calendar Contest
             
Testimonials

Now Available at Foundation Care

Meet Our Pharmacist

 Follow Us On...

 

 Meet Our Pharmacist

Katie Douglas is the newest pharmacist to join the Foundation Care team.  She is originally from Erie, Illinois.  After completing her bachelor’s degree in chemistry from Eureka College, she received her Doctorate of Pharmacy from Southern Illinois University Edwardsville.  In her spare time Katie enjoys traveling, spending time with family, and planning her upcoming wedding.  Feel free to give Katie a call at (877) 291-1122 to ask questions about your medication therapy!

 Testimonials

The service provided to me is excellent.
-Louisville, KY-

Everyone has been so nice and helpful!  Thank you!
-Vienna,OH-
           
I was pleasantly surprised by how easy you made it to order. You made it a simple, painless process!  Thank you so much!
-Los Angeles, CA-

You guys are tremendous!
-Marina Del Rey, CA-

 

Greetings,

Thanks again for allowing Foundation Care to be your pharmacy!

Cayston Restrictions Lifted space

On September 4, 2012, Gilead Sciences Inc. announced that the supply restrictions on Cayston (aztreonam for inhalation solution) have been lifted.  Foundation Care is now able to provide ALL patients nationwide (current, new, and previously declined) with the medication as prescribed by a physician.

If you need assistance in obtaining your Cayston medication, please contact Foundation Care today at (877) 291-1122. 

For more information, click here.

space
Calendar Contest:  Deadline September 15, 2012 space

The countdown is on!  Don’t forget to send us your photos for a chance to be included in our 2013 calendar and win a $50 VISA Gift Card.  Our calendars are distributed to patients, physicians, clinics and anyone else that requests a copy.  It’s a great opportunity to show your creativity.

Click here for the official rules.

space

Coming Soon:  Our Website Gets a Facelift

space
Soon, Foundation Care’s website will have a new look in addition to features such as “Schedule an Immunization” and “Transfer Your Prescription.”   

Also, the online ordering system will be updated.  Patients will soon be able to view their entire Foundation Care prescription history as well as any medical equipment or supplies ordered from our pharmacy.  Current customers utilizing our online ordering system will be sent instructions and detailed information outlining the changes. 

Be assured, we will make this transition as smooth as possible!
space
 Now Available at Foundation Care space

VIOKACE™ (pancrelipase) Tablets

On August 14, Aptalis Pharma announced that VIOKACE™ (pancrelipase) Tablets are now commercially available in the U.S.  As described in the press release issued by Aptalis, “Approved by the U.S. Food and Drug Administration on March 1st, VIOKACE, in combination with a proton pump inhibitor, is indicated in adults for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy.  

Frank Verwiel, M.D., President and Chief Executive Officer of Aptalis Pharma, stated, "We are very pleased to be able to make VIOKACE available in the U.S. The launch of VIOKACE brings an uncoated pancreatic enzyme to market, providing another important treatment option for adult patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy.""

Pertzye™ (pancrelipase) Pancreatic Enzyme            

As stated in a press release dated May, 2012, “Digestive Care, Inc. announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for PERTZYE™, indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions.  PERTZYE is a unique pancreatic enzyme product containing bicarbonate-buffered enteric-coated microspheres and is protected by several U.S. and international patents. The PERTZYE formulation was previously marketed by DCI for over a decade under the trade name PANCRECARB® MS-16.”

To order either of these medications, contact Foundation Care today at 877-291-1122.  We will be happy to coordinate this with your prescriber!

space


space
Have a wonderful day!

Foundation Care
4010 Wedgeway Court
Earth City, MO 63045
Toll-Free: (877) 291-1122
Fax: (877) 291-1155
Email: help@foundcare.com
space

Generated by Learn more